Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Archit Organosys's 3-Year ROIIC % for the quarter that ended in Mar. 2026 was -19.68%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Archit Organosys's 3-Year ROIIC % or its related term are showing as below:
BOM:524640's 3-Year ROIIC % is ranked worse than 76.19% of 1529
companies
in the Chemicals industry
Industry Median: 0.1
vs BOM:524640: -19.68
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Archit Organosys 3-Year ROIIC % Related Terms
Archit Organosys 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Archit Organosys's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Archit Organosys's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Archit Organosys 3-Year ROIIC % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Archit Organosys's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Archit Organosys's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Archit Organosys (BOM:524640) has a 3-Year ROIIC % of -19.68 as of Mar. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Archit Organosys and its competitors. According to the industry distribution chart, Archit Organosys ranks #1165 out of 1529 companies in the Chemicals industry, placing it in the top 76.2%.
Is Archit Organosys' 3-Year ROIIC % too high?
Archit Organosys' current 3-Year ROIIC % is -19.68. Based on the distribution chart, Archit Organosys ranks #1165 out of 1529 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Archit Organosys has a GF Score™ of 64/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Archit Organosys' 3-Year ROIIC % compare to DOW?
According to the Chemicals industry distribution chart, Archit Organosys ranks #1165 out of 1529 companies for 3-Year ROIIC %. This places Archit Organosys in the lower half of its industry. The industry median 3-Year ROIIC % is 0.10. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Chemicals company?
The median 3-Year ROIIC % among Chemicals companies is 0.10, based on 1,529 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Archit Organosys and its competitors. For the Chemicals industry, the median 3-Year ROIIC % is 0.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Archit Organosys's current 3-Year ROIIC % is -19.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Archit Organosys stock overvalued right now?
Based on GuruFocus' analysis, Archit Organosys (BOM:524640) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹55.49, compared to a current price of ₹63.85 — trading 15.1% above its estimated fair value. The current 3-Year ROIIC % is -19.68. Archit Organosys' overall GF Score™ is 64/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Archit Organosys (BOM:524640), the current 3-Year ROIIC % is -19.68 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Archit Organosys (BOM:524640) Overvalued in 2026?
Based on GuruFocus' analysis, Archit Organosys stock appears to be overvalued.
The current stock price of ₹63.85 is trading 15.1% above its estimated GF Value™ of ₹55.49.
GuruFocus considers Archit Organosys to be Modestly Overvalued.
Key valuation signals for BOM:524640:
3-Year ROIIC %: -19.68
GF Value™: ₹55.49 vs. price of ₹63.85 (15.1% above fair value)
No single metric tells the full story. See the BOM:524640 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Archit Organosys Ltd is mainly engaged in the manufacturing and selling of various chemical products, including alkali chemicals, inorganic chemicals, organic chemicals, pesticides and insecticides, dyes, and dyestuff. The company mainly manufactures and trades chemicals such as Monochloro Acetic Acid (MCA), Sodium Monochloro Acetate (SMCA), Chloroacetyl Chloride, and Trichloroacetyl Chloride (TCAC). It operates in a single segment identified as manufacturing and trading of dyes, chemicals, and pigments. Geographically, it derives the majority of its revenue from India and also exports products to other countries.
64GF Score
Get the complete analysis for BOM:524640
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524640 has been successfully added to your 
